Alivexis, Inc. (“Alivexis”), a preclinical-stage computation-driven drug discovery company, will present at the 2025 BIO International Convention being held June 16-19, 2025 in Boston, MA. The presentation will take place on Tuesday, June 17 at 3:30PM in Room 153C at the Boston Convention & Exhibition Center.

The corporate update will highlight Alivexis’ updates and progress on its pipeline in oncology, chronic inflammation and autoimmune diseases and on its breakthrough computational drug discovery platform, ModBind™.

Alivexis’ presentation details are as follows:
Event: 2025 BIO International Convention
Presentation Date/Time: Tuesday, June 17 at 3:30PM (Eastern Time)
Venue: Room 153C at the Boston Convention & Exhibition Center
Presenter: S. Roy Kimura, co-founder and CEO

To schedule a meeting with the Company’s management at the convention, please submit a meeting request through the BIO One-on-One Partnering™ system or contact info@alivexis.com

Alivexis to Present at the 2025 BIO International Convention(PDF)